Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

Non-invasive prenatal test as good as invasive methods, say scientists

14 January 2013

By Dr Daniel Grimes

Appeared in BioNews 688

US biotech company Verinata Health has reported sequencing fetal DNA taken from pregnant women's blood to test for genetic abnormalities.

Researchers took blood samples from 11 pregnant women carrying fetuses with genetic abnormalities and by sequencing the cell-free fetal DNA in the woman's blood were able to identify the abnormalities present.

'Our study shows that medically relevant information currently available only through an invasive prenatal procedure is accessible non-invasively from a single maternal blood sample', said Dr Richard Rava, chief scientific officer of Verinata Health.

Normally, prenatal diagnostic testing requires invasive tests, such as amniocentesis and chorionic villus sampling, which carry a low risk of miscarriage. A mapping process called karyotyping is then performed which provides doctors with a picture of the broad shape of chromosomes, allowing major defects in structure to be discovered. Doctors can obtain information about the rest of the genome through microarray techniques, but this requires the extraction of placental tissue.

The new technique was able to pick up the vast majority of the defects found by the more traditional approaches. 'Accuracy is greater than 99 percent', Dr Rava told TIME. The researchers said the study showed that the karyotypes produced were equivalent to those produced through microarray techniques.

Moreover, by using the new approach the scientists could potentially detect many more genetic defects than would be found using chromosome karyotyping.

Not only does the new method represent a safer alternative, the researchers could also increase the resolution with which the DNA of a fetus can be scrutinised. Professor Cynthia Morton, a geneticist at Harvard University, told Bloomberg that this technology 'could largely replace invasive testing'.

Since March 2012, Verinata has sold a blood test called Verifi that can detect conditions, where there is an extra copy of a chromosome - called trisomy - including Down's syndrome. The company now plans to expand that test to include some of the additional genetic aberrations that can be identified by fetal DNA sequencing.

'It's not going to happen tomorrow', Dr Rava told TIME, but the 'paper demonstrates it's technically feasible'.

The study was published in the American Journal of Human Genetics.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

13 April 2015 - by Dr Ainsley Newson and Associate Professor Stacy Carter 
In March, Sequenom revealed that its MaterniT21 non-invasive prenatal test has detected potential cancer in some pregnant women. This is a good thing, right? Women in the prime of their lives receiving information that may catch a cancer early. But, we suggest, it is not this simple. ...
09 March 2015 - by Kirsty Oswald 
US company Sequenom has revealed that its prenatal blood test - MaterniT21 PLUS - has detected potential cancer in at least 40 expectant mothers since its launch three years ago...
10 March 2014 - by Dr Victoria Burchell 
A test using a simple blood sample from the expectant mother should soon be the primary screening method for Down's syndrome, according to a report from the Royal College of Obstetricians and Gynaecologists (RCOG)...
10 June 2013 - by James Brooks 
A test using only a blood sample taken from a pregnant woman is more reliable than current checks in indicating the likelihood of Down's syndrome, say researchers...
07 May 2013 - by James Brooks 
I know what they say about yesterday's news and today's fish and chip paper but what I'm about to tell you is six months old and still a little way off as a headline...

10 December 2012 - by Dr Lux Fatimathas 
More sensitive prenatal testing of fetal DNA could improve the detection of genetic diseases, studies find...
26 November 2012 - by Dr Lux Fatimathas 
Non-invasive pre-natal screening for certain abnormalities in fetal chromosomes should be offered to at-risks mothers, recommends the American College of Obstetricians and Gynecologists...
13 December 2010 - by Julianna Photopoulos 
Scientists have scanned the entire DNA of an unborn child from the mother's blood sample for the first time to safely check for genetic disorders...
08 December 2008 - by Evelyn Harvey 
By Evelyn Harvey: A new method for early detection of genetic diseases in unborn babies using a simple blood test can detect the inherited condition beta-thalassemia, according to a study published in Proceedings of the National Academy of Sciences. Although the technique, which analyses cell free fetal DNA (cffDNA) present...
13 October 2008 - by Lorna Stewart 
Scientists at Stanford University in California, US have developed a new non-invasive prenatal test for Down's syndrome. Stephen Quake and colleagues successfully identified presence and absence of fetal chromosomal abnormality in 18 pregnant women from maternal blood samples. The work is published this month in the journal...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation